Screener
Arcutis Biotherapeutics, Inc. ARQT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $34,121 | $42,907 |
| Restricted cash | 308 | 308 |
| Marketable securities | 204,431 | 178,075 |
| Trade receivables, net | 155,162 | 146,229 |
| Inventory | 38,879 | 22,634 |
| Prepaid expenses and other current assets | 34,770 | 21,079 |
| Total current assets | 467,671 | 411,232 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s short-term investments?
- Arcutis Biotherapeutics, Inc. (ARQT) reported short-term investments of $204.43M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s short-term investments changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s short-term investments increased by 73.1% year-over-year, from $118.08M to $204.43M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s short-term investments has grown at a -4.1% compound annual growth rate (CAGR), from $219.36M to $178.08M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Arcutis Biotherapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude